Childhood Leukemias

Childhood Leukemias

  • Electronic book text
Edited by 

List price: US$180.00

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

New insights into the molecular biology of childhood leukemias have stimulated numerous advances in diagnostic methods, strategies for risk assessment and the development of novel therapy for genetic subtypes of the diseases. Fully revised and updated, this new edition of Childhood Leukemias provides the most comprehensive, clinically-oriented and authoritative reference dedicated to these diseases. Beginning with an overview of history, cell biology, and pathology, subsequent chapters review approaches in the evaluation and management of specific leukemias, new therapeutic development and the unique pharmacodynamics and pharmacogenetics of individual patients. New chapters include epigenetics of leukemias, leukemias in patients with Down syndrome and leukemia in adolescents and young adults. The final section covers the complications associated with the disease or its treatment and supportive care during and after treatment. Authored by leading experts, this is a 'must-have' for any physician or investigator who deals with leukemias in childhood.show more

Product details

  • Electronic book text
  • CAMBRIDGE UNIVERSITY PRESS
  • Cambridge University Press (Virtual Publishing)
  • Cambridge, United Kingdom
  • Revised
  • 3rd Revised edition
  • 158 b/w illus. 51 colour illus. 120 tables
  • 1139511920
  • 9781139511926

Review quote

Review of the previous editions: '... comprehensively referenced and the indexing is simple to use ... informative and relevant ... I would commend the book to anyone looking for an up-to-date and comprehensive reference monograph on childhood leukaemia.' The Bulletin of The Royal College of Pathologists 'This is an exceptional book that's highly extensive in coverage of the very complex field of leukemias among children and to some extent, adolescents. The information in it is presented well, and written very clearly. The fact that it is in its third edition speaks for itself. The first and second editions had to have been successful by providing great value in terms of not just the knowledge but also its ease of use.' Nano Khilnani, Biz India Online News (www.bizindia.net)show more

About Ching-Hon Pui

Ching-Hon Pui is Chair of the Department of Oncology, Fahad Nassar Al-Rashid Chair of Leukemia Research and co-Director of the Hematological Malignancies Program at St Jude's Children's Research Hospital, Memphis, TN, USA.show more

Table of contents

Preface; Part I. History and General Issues: 1. History of leukemia Paul Gaynon, Toska Zomorodian and Donald Pinkel; 2. Diagnosis and classification Mihaela Onciu and Ching-Hon Pui; 3. Epidemiology and etiology Logan Spector, Bridget Charbonneau and Leslie L. Robison; Part II. Cell Biology and Pathobiology: 4. Immunophenotyping Fred G. Behm; 5. Immunoglobulin and T-cell receptor gene rearrangements Jacques J. M. van Dongen and Anton W. Langerak; 6. Cytogenetics of acute leukemias Susana C. Raimondi; 7. Molecular genetics of acute lymphoblastic leukemias Charles Mullighan; 8. Molecular genetics of acute myeloid leukemia Tanja A. Gruber and James R. Downing; 9. Epigenetics of leukemias William Stevenson and Guillermo Garcia-Manero; 10. Genetics and cellular drug resistance in acute leukemia Monique L. den Boer and Rob Pieters; 11. Heritable predispositions to childhood hematologic malignancies Doan Le, Kevin Shannon and Beverly J. Lange; Part III. Evaluation and Treatment: 12. Pharmacokinetic, pharmacodynamic, and pharmacogenetic considerations Stephen W. Paugh, Mary V. Relling and Williams E. Evans; 13. Acute lymphoblastic leukemia Ching-Hon Pui; 14. Relapsed acute lymphoblastic leukemia Gunter Henze and Arend von Stackelberg; 15. B-cell acute lymphoblastic leukemia and Burkitt lymphoma John T. Sandlund and Mihaela Onciu; 16. Acute myeloid leukemia Jeffrey E. Rubnitz, Hiroto Inaba and Raul Ribeiro; 17. Relapsed acute myeloid leukemia Ursula Creutzig; 18. Myelodysplastic syndromes Henrik Hasle; 19. Chronic myeloproliferative disorders Charlotte M. Niemeyer and Franco Locatelli; 20. Leukemias in patients with Down syndrome Jeffrey W. Taub, April Sorrell and James A. Whitlock; 21. Treatment of adolescents and young adults with acute lymphoblastic leukemia James Nachman; 22. Hematopoietic stem cell and natural killer cell transplantation Wing Leung and Michael A. Pulsipher; 23. Treatment in the underprivileged countries Raul Ribeiro, Scott C. Howard and Ching-Hon Pui; 24. Antibody-targeted therapy Alan S. Wayne; 25. Adoptive cellular immunotherapy Hyoung Jin Kang, Cliona M. Rooney and Helen Heslop; 26. Gene therapy: methods and applications Ulrike Gerdemann, Martin Pule and Malcolm K. Brenner; 27. Development therapeutics Sima Jeha; 28. Minimal residual disease Dario Campana, Andrea Biondi and Jacques J. M. van Dongen; Part IV. Complications and Supportive Care: 29. Acute complications Scott C. Howard, Raul Ribeiro and Ching-Hon Pui; 30. Late complications after leukemia therapy Melissa Hudson; 31. Therapy-related leukemias Carolyn A. Felix; 32. Infectious complications Hana Hakim and Patricia M. Flynn; 33. Hematologic supportive care Fariba Navid and Victor M. Santana; 34. Pain management Doralina L. Anghelescu and Roland Kaddoum; 35. Psychosocial issues Sean Phipps, Vida L. Tyc, Heather Conklin and Kevin Krull; 36. Nursing care Jami S. Gattuso, Martha May and Michele Pritchard; Index.show more